Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran.
Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
Cancer Med. 2020 Jul;9(13):4808-4822. doi: 10.1002/cam4.3068. Epub 2020 May 4.
Helicobacter pylori is known as an important determinant of preneoplastic lesions or gastric cancer (GC) risk. The bacterial genotypes may determine the clinical outcomes. However, the evidence for these associations has varied between and within continents, and the actual effect of each gene and corresponding allelic variants are still debatable. In recent years, two new models have been proposed to predict the risk of GC; the phylogeographic origin of H. pylori strains and a disrupted co-evolution between H. pylori and its human host, which potentially explain the geographic differences in the risk of H. pylori-related cancer. However, these models and earlier ones based on putative virulence factors of the bacterium may not fully justify differences in the incidence of GC, reflecting that new theories should be developed and examined. Notably, the new findings also support the role of ancestry-specific germline alteration in contributing to the ethnic/population differences in cancer risk. Moreover the high and low incidence areas of GC have shown differences in transmission ecology, largely affecting the composition of H. pylori populations. As a new hypothesis, it is proposed that any high-risk population may have its own specific risk loci (or variants) as well as new H. pylori strains with national/maybe regional gene pools that should be considered. The latter is seen in the Americas where the rapid evolution of distinct H. pylori subpopulations has been occurred. It is therefore proposed that the deep sequencing of both H. pylori and its human host is simultaneously performed in GC patients and age-sex-matched controls from high-risk areas. The expression and functional activities of the identified new determinants of GC must then be assessed and matched with human and pathogen ancestry, because some of risk loci are ancestry-specific. In addition, potential study-level covariates and moderator variables (eg physical conditions, life styles, gastric microbiome, etc) linked to causal relationships, and their impact, should be recognized and controlled.
幽门螺杆菌被认为是癌前病变或胃癌(GC)风险的重要决定因素。细菌基因型可能决定临床结果。然而,这些关联的证据在不同大陆之间和内部存在差异,并且每个基因和相应等位基因变异的实际效果仍存在争议。近年来,提出了两种新的模型来预测 GC 的风险;幽门螺杆菌菌株的系统发育起源和幽门螺杆菌与其人类宿主之间的破坏协同进化,这可能解释了与幽门螺杆菌相关的癌症风险的地理差异。然而,这些模型和基于细菌假定毒力因子的早期模型可能不能完全说明 GC 发病率的差异,反映出应该开发和检验新的理论。值得注意的是,新发现还支持种系改变在导致癌症风险的种族/人群差异中的作用。此外,GC 的高发和低发地区在传播生态方面存在差异,这在很大程度上影响了幽门螺杆菌种群的组成。作为一个新的假设,提出任何高风险人群都可能具有其自身特定的风险基因座(或变体)以及具有国家/可能的区域基因库的新幽门螺杆菌菌株,这应该被考虑。这在美洲可以看到,那里独特的幽门螺杆菌亚群已经迅速进化。因此,建议在高危地区的 GC 患者和年龄、性别匹配的对照中同时对幽门螺杆菌及其人类宿主进行深度测序。然后必须评估所确定的 GC 新决定因素的表达和功能活性,并与人类和病原体的祖先相匹配,因为一些风险基因座是特定于祖先的。此外,应认识到并控制与因果关系相关的潜在研究水平协变量和调节变量(例如身体状况、生活方式、胃微生物组等)及其影响。